marijuana stocks

GW Pharmaceuticals Continues To Rally: A Technical Look

GW Pharmaceuticals Plc (NASDAQ:GWPH) shares were trading higher by $2.20 (2.5 percent) at $97.86 in Monday’s session. The darling of the marijuana sector is following through on Friday’s impressive nearly $11.00 rally ($84.58 to $95.66). It should be noted Friday’s rally took place on extremely high volume for the issue of nearly two million shares vs. its 20-day average of 325,000.

Investors may be anticipating positive results as the company is set to release additional Epidiolex data at the American Academy of Neurology that should inform developments in other orphan epilepsy. Over the past year, the issue has fluctuated primarily based on news concerning the drug and not so much on developments related to marijuana.

See Also: 15 Marijuana Stocks To Watch In 2015

After a bit off profit-taking off the open, it quickly found support just $0.16 from its opening price ($94.23 vs. $94.39) before ripping north once again. At time of writing, it easily surpassed Friday’s high ($95.92), reaching $98.43 before taking a breather.

The all-time high for the issue was made in July 2014, at the pinnacle of the “pot stock” mania at $111.46, before cascading to $58.16 in October.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$FNREF Provides Update on California Cannabis Product Offerings

Finore Mining Provides Update on California Cannabis Product Offerings and Name Change…

Charlotte’s Web Holdings, Inc. (CWBHF) Steps up to Support Research to Address FDA’s Request for More Scientific Data

Charlotte’s Web Steps up to Support Research to Address FDA’s Request for…

$NTRR Setting New Milestones in Colorado and Cannabis Industry

NTRR: Banking Breakthrough in Colorado a New Milestone in Booming Cannabis Industry’s…

Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2024 Financial Results on May 13, 2024

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13,…